Abstract
Human fungal infections caused by opportunistic fungi generally do not cause lesions in healthy individuals but rather in patients who are immunocompromised in some manner. In the oral and maxillofacial region, these can be principally attributed to oral candidosis as well as other potentially life-threatening opportunistic fungal infections, such as aspergillosis, mucormycosis, blastomycosis, and histoplasmosis. Although they are considered as systemic mycoses, in the orofacial area, they may also be involved with intraoral manifestations. Microscopic examination of cultures from biopsies or swabs is essential to diagnose and differentiate between these pathologies. This chapter outlines the carriage of Candida species, the etiology of diseases caused by Candida, as well as the clinical presentation of diseases caused by fungi in the oral and maxillofacial area. Factors important in the management of patients with these diseases, including diagnostic techniques and specific antifungal treatment, are presented. Finally, the role of Candida in the development of oral squamous cell carcinoma is discussed.
This is a preview of subscription content, log in via an institution to check access.
References
Abreu e Silva MA, Salum FG, Figueiredo MA, Cherubini K. Important aspects of oral paracoccidioidomycosis–a literature review. Mycoses. 2013;56(3):189–99.
Al-Fattani MA, Douglas LJ. Penetration of Candida biofilms by antifungal agents. Antimicrob Agents Chemother. 2004;48(9):3291–7.
Al-Karaawi ZM, Manfredi M, Waugh AC, McCullough MJ, Jorge J, Scully C, Porter SR. Molecular characterization of Candida spp. isolated from the oral cavities of patients from diverse clinical settings. Oral Microbiol Immunol. 2002;17:44–9.
Alnuaimi AD, Wiesenfeld D, O’Brien-Simpson NM, Reynolds EC, Peng B, McCullough MJ. The development and validation of a rapid genetic method for species identification and genotyping of medically important fungal pathogens using high resolution melting curve analysis. Mol Oral Microbiol. 2014;29:117–30.
Alnuaimi AD, Wiesenfeld D, O’Brien-Simpson NM, Reynolds EC, McCullough MJ. Oral Candida colonization in oral cancer patients and its relationship with traditional risk factors of oral cancer: a matched case-control study. Oral Oncol. 2015;51:139–45.
Alnuaimi AD, Ramdzan AN, Wiesenfeld D, O’Brien-Simpson NM, Kolev SD, Reynolds EC, McCullough MJ. Candida virulence and ethanol-derived acetaldehyde production in oral cancer and non-cancer subjects. Oral Dis. 2016;22(8):805–14.
Appleton SS. Candidiasis: pathogenesis, clinical characteristics, and treatment. J Calif Dent Assoc. 2000;28(12):942–8.
Aras MH, Kara MI, Erkilic S, Ay S. Mandibular mucormycosis in immunocompromised patients: report of 2 cases and review of the literature. J Oral Maxillofac Surg. 2012;70(6):1362–8.
Arendorf TM, Walker DM. The prevalence and intra-oral distribution of Candida albicans in man. Arch Oral Biol. 1980;25(1):1–10.
Arendorf TM, Walker DM. Tobacco smoking and denture wearing as local aetiological factors in median rhomboid glossitis. Int J Oral Surg. 1984;13(5):411–5.
Axéll T, Holmstrup P, Kramer IRH, Pindborg JJ, Shear M. International seminar on oral leukoplakia and associated lesions related to tobacco habits. Commun Dent Oral Epidemiol. 1984;12:145–54.
Azenha MR, Caliento R, Brentegani LG, de Lacerda SA. A retrospective study of oral manifestations in patients with paracoccidioidomycosis. Braz Dent J. 2012;23(6):753–7.
Baillie GS, Douglas LJ. Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob Agents Chemother. 1998;42:1900–5.
Baillie GS, Douglas LJ. Matrix polymers of candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother. 2000;46:397–403.
Banoczy J. Follow-up studies in oral leukoplakia. J Maxillofac Surg. 1977;5(1):69–75.
Bánóczy J, Sugár L. Longitudinal studies in oral leukoplakias. J Oral Pathol. 1972;1:265–72.
Barbosa de Paulo LF, Silva de Faria L, Francisco Durighetto A Jr. Endemic oral paracoccidioidomycosis: clinical presentation, management, and outcomes. Int J Infect Dis. 2014;19:109–10.
Barrett AW, Kingsmill VJ, Speight PM. The frequency of fungal infection in biopsies of oral mucosal lesions. Oral Dis. 1998;4(1):26–31.
Bartie KL, Williams DW, Wilson MJ, Potts AJ, Lewis MA. Differential invasion of Candida albicans isolates in an in vitro model of oral candidosis. Oral Microbiol Immunol. 2004;19(5):293–6.
Bastiaan RJ, Reade PC. The prevalence of Candida albicans in the mouths of tobacco smokers with and without oral mucous membrane keratoses. Oral Surg Oral Med Oral Pathol. 1982;53:148–51.
Beausejour A, Grenier D, Goulet JP, Deslauriers N. Proteolytic activation of the interleukin-1beta precursor by Candida albicans. Infect Immun. 1998;66(2):676–81.
Biswas S, Van Dijck P, Datta A. Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol Mol Biol Rev. 2007;71(2):348–76.
Bjorkholm B, Falk P, Engstrand L, Nyren O. Helicobacter pylori: resurrection of the cancer link. J Intern Med. 2003;253(2):102–19.
Blank F, Chin O, Just G, Meranze DR, Shimkin MB, Weider R. Carcinogens from fungi pathogenic for man. Cancer Res. 1968;28:2276–81.
Blankenship JR, Mitchell AP. How to build a biofilm: a fungal perspective. Curr Opin Microbiol. 2006;9: 588–94.
Borromeo GL, McCullough MJ, Reade PC. Quantitation and morphotyping of Candida albicans from healthy mouths and from mouths affected by erythematous candidosis. J Med Vet Mycol. 1992;30:477–80.
Brand A. Hyphal growth in human fungal pathogens and its role in virulence. Int J Microbiol. 2012;2012:517529.
Brazao-Silva MT, Andrade MF, Franco T, Ribeiro RI, Silva Wdos S, Faria G, Faria PR, Cardoso SV, Loyola AM. Paracoccidioidomycosis: a series of 66 patients with oral lesions from an endemic area. Mycoses. 2011;54(4):e189–95.
Budtz-Jorgensen E. Candida-associated denture stomatitis and angular cheilitis. In: Samaranayake LP, MacFarlane TW, editors. Oral candidosis, Chap 9. London: Wright-Butterworth & Co. Ltd; 1990.
Burnham R, Bridle C. Aspergillosis of the maxillary sinus secondary to a foreign body (amalgam) in the maxillary antrum. Br J Oral Maxillofac Surg. 2009;47(4):313–5.
Calderone RA. Candida and candidosis. Washington, DC: ASM Press; 2002.
Calderone RA, Braun PC. Adherence and receptor relationships of Candida albicans. Microbiol Rev. 1991;55:1–20.
Calderone RA, Fonzi WA. Virulence factors of Candida albicans. Trends Microbiol. 2001;9(7):327–35.
Cannon RD, Chaffin WL. Oral colonization by Candida albicans. Crit Rev Oral Biol Med. 1999;10(3):359–83.
Cannon RD, Holmes AR, Mason AB, Monk BC. Oral Candida: clearance, colonization, or candidiasis? J Dent Res. 1995;74(5):1152–61.
Cartledge JD, Midgley J, Gazzard BG. Non-albicans oral candidosis in HIV-positive patients. J Antimicrob Chemother. 1999;43(3):419–22.
Cawson RA, Binnie WH. Candida leukoplakia and carcinoma – possible relationship. In: Dabelsteen E, Mackenzie IC, Squier CA, editors. Oral premalignancy. Iowa City: University of Iowa Press; 1977. p. 59–66.
Cawson RA, Lehner T. Chronic hyperplastic candidiasis–candidal leukoplakia. Br J Dermatol. 1968;80:9–16.
Chandra J, Mukherjee PK, Ghannoum MA. In vitro growth and analysis of Candida biofilms. Nat Protoc. 2008;3(12):1909–24.
Chen YC, Wu CC, Chung WL, Lee FJ. Differential secretion of Sap4-6 proteins in Candida albicans during hyphae formation. Microbiology. 2002;148(Pt 11): 3743–54.
Cho H, Lee KH, Colquhoun AN, Evans SA. Invasive oral aspergillosis in a patient with acute myeloid leukaemia. Aust Dent J. 2010;55(2):214–8.
Clarkson JE, Worthington HV, Eden OB. Interventions for preventing oral candidiasis for patients with cancer receiving treatment. Cochrane Database Syst Rev (Online). 2007;CD003807.
Coleman DC, Sullivan DJ, Bennett DE, Moran GP, Barry HJ, Shanley DB. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS. 1997;11(5):557–67.
Coogan MM, Greenspan J, Challacombe SJ. Oral lesions in infection with human immunodeficiency virus. Bull World Health Organ. 2005;83(9):700–6.
Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology. 2007;133(2):659–72.
Costa F, Polini F, Zerman N, Robiony M, Toro C, Politi M. Surgical treatment of Aspergillus mycetomas of the maxillary sinus: review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103(6):e23–9.
Davey ME, O’Toole GA. Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev. 2000;64(4):847–67.
De Bernardis F, Mondello F, San Millan R, Ponton J, Cassone A. Biotyping and virulence properties of skin isolates of Candida parapsilosis. J Clin Microbiol. 1999;37(11):3481–6.
Delgado WA, Romero de Leon E. 14th international congress IAOP/AAOMP clinical pathology conference case 6. Head Neck Pathol. 2008;2(4):298–301.
Denning DW, Chakrabarti A. Pulmonary and sinus fungal diseases in non-immunocompromised patients. Lancet Infect Dis. 2017;17:e357.
Dhiman N, Hall L, Wohlfiel SL, Buckwalter SP, Wengenack NL. Performance and cost analysis of matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine identification of yeast. J Clin Microbiol. 2011;49(4):1614–6.
do Prado Gomes Pedreira R, de Carli ML, Beijo LA, Nonogaki S, Pereira AA, Junior NV, Sperandio FF, Hanemann JA. Oral paracoccidioidomycosis granulomas are predominantly populated by CD163+ multinucleated Giant cells. Mycopathologia. 2016;181(9–10):709–16.
Dodson TB, Perrott DH, Leonard MS. Nonhealing ulceration of oral mucosa. J Oral Maxillofac Surg. 1989;47(8):849–52.
Dojcinovic I, Richter M. Mucormycoses: serious complication of high-dose corticosteroid therapy for traumatic optic neuropathy. Int J Oral Maxillofac Surg. 2008;37(4):391–4.
Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis. 2001;33(8): 1387–92.
Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15(2):167–93.
Douglas LJ. Candida proteinases and candidosis. Crit Rev Biotechnol. 1988;8(2):121–9.
Dwivedi PP, Mallya S, Dongari-Bagtzoglou A. A novel immunocompetent murine model for Candida albicans-promoted oral epithelial dysplasia. Med Mycol. 2009;47(2):157–67.
Ellepola AN, Morrison CJ. Laboratory diagnosis of invasive candidiasis. J Microbiol. 2005;43 Spec No: 65–84.
Ellepola AN, Samaranayake LP. Oral candidal infections and antimycotics. Crit Rev Oral Biol Med. 2000;11(2): 172–98.
Eyerich K, Foerster S, Rombold S, Seidl HP, Behrendt H, Hofmann H, Ring J, Traidl-Hoffmann C. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J Invest Dermatol. 2008;128(11):2640–5.
Eyre J, Nally FF. Oral candidosis and carcinoma. Br J Dermatol. 1971;85:73–5.
Falworth MS, Herold J. Aspergillosis of the paranasal sinuses. A case report and radiographic review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81(2):255–60.
Fantini MC, Pallone F. Cytokines: from gut inflammation to colorectal cancer. Curr Drug Targets. 2008;9(5): 375–80.
Farah CS, Ashman RB, Challacombe SJ. Oral candidosis. Clin Dermatol. 2000;18:553–62.
Farah CS, Lynch N, McCullough MJ. Oral fungal infections: an update for the general practitioner. Aust Dent J. 2010;55(Suppl 1):48–54.
Farah CS, Amos K, Leeson R, Porter S. Candida species in patients with oral dysesthesia: a comparison of carriage among oral disease states. J Oral Pathol Med. 2018. https://doi.org/10.1111/jop.12675.
Fenn JP, Segal H, Barland B, Denton D, Whisenant J, Chun H, Christofferson K, Hamilton L, Carroll K. Comparison of updated Vitek yeast biochemical card and API 20C yeast identification systems. J Clin Microbiol. 1994;32(5):1184–7.
Field EA, Field JK, Martin MV. Does Candida have a role in oral epithelial neoplasia? J Med Vet Mycol. 1989;27:277–94.
Firth NA, O’Grady JF, Reade PC. Oral squamous cell carcinoma in a young person with candidosis endocrinopathy syndrome: a case report. Int J Oral Maxillofac Surg. 1997;26(1):42–4.
Folk GA, Nelson BL. Oral Histoplasmosis. Head Neck Pathol. 2017;11(4):513–6.
Fong LY, Lui CP, NG WL, Newberne PM. The effect of N-nitrosodimethylamine and N-nitroso-N-benzylmethylamine on [3H]thymidine incorporation into the DNA of target and non-target tissues in the zinc-deficient rat. Cancer Lett. 1986;30:61–71.
Fu Y, Ibrahim AS, Fonzi W, Zhou X, Ramos CF, Ghannoum MA. Cloning and characterization of a gene (LIP1) which encodes a lipase from the pathogenic yeast Candida albicans. Microbiology. 1997;143:331–40.
Fukayama M, Calderone RA. Adherence of cell surface mutants of Candida albicans to buccal epithelial cells and analyses of the cell surface proteins of the mutants. Infect Immun. 1991;59(4):1341–5.
Ganesh P, Nagarjuna M, Shetty S, Kumar P, Bhat V, Salins PC. Invasive aspergillosis presenting as swelling of the buccal mucosa in an immunocompetent individual. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119(2):e60–4.
Gavito-Higuera J, Mullins CB, Ramos-Duran L, Sandoval H, Akle N, Figueroa R. Sinonasal fungal infections and complications: a pictorial review. J Clin Imaging Sci. 2016;6:23.
Gee SF, Joly S, Soll DR, Meis JF, Verweij PE, Polacheck I, Sullivan DJ, Coleman DC. Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo. J Clin Microbiol. 2002;40(2):556–74.
Ghannoum MA. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev. 2000;13(1):122–43.
Ginsburg I, Fligiel SE, Kunkel RG, Riser BL, Varani J. Phagocytosis of Candida albicans enhances malignant behavior of murine tumor cells. Science. 1987;238(4833):1573–5.
Glasmacher A, Cornely O, Ullmann AJ, Wedding U, Bodenstein H, Wandt H, Boewer C, Pasold R, Wolf HH, Hänel M, Dölken G, Junghanss C, Andreesen R, Bertz H, Itraconazole Research Group of Germany. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia. J Antimicrob Chemother. 2006;57: 317–25.
Godoy H, Reichart PA. Oral manifestations of paracoccidioidomycosis. Report of 21 cases from Argentina. Mycoses. 2003;46(9–10):412–7.
Goh LC, Shakri ED, Ong HY, Mustakim S, Shaariyah MM, Ng WSJ, Zulkiflee AB. A seven-year retrospective analysis of the clinicopathological and mycological manifestations of fungal rhinosinusitis in a single-centre tropical climate hospital. J Laryngol Otol. 2017;131(9):813–6.
Gonzalez Ballester D, Gonzalez-Garcia R, Moreno Garcia C, Ruiz-Laza L, Monje Gil F. Mucormycosis of the head and neck: report of five cases with different presentations. J Craniomaxillofac Surg. 2012;40(7): 584–91.
Gow NA, van de Veerdonk FL, Brown AJ, Netea MG. Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol. 2012;10(2):112–22.
Gropp K, Schild L, Schindler S, Hube B, Zipfel PF, Skerka C. The yeast Candida albicans evades human complement attack by secretion of aspartic proteases. Mol Immunol. 2009;47(2–3):465–75.
Guggenheimer J, Moore PA, Rossie K, Myers D, Mongelluzzo MB, Block HM, Weyant R, Orchard T. Insulin-dependent diabetes mellitus and oral soft tissue pathologies: II. Prevalence and characteristics of Candida and Candidal lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89(5):570–6.
Hattori M, Yoshiura K, Negi M, Ogawa H. Keratinolytic proteinase produced by Candida albicans. Sabouraudia. 1984;22(3):175–83.
Hazen KC. Participation of yeast cell surface hydrophobicity in adherence of Candida albicans to human epithelial cells. Infect Immun. 1989;57(7):1894–900.
Hoegl L, Thoma-Greber E, Röcken M, Korting HC. Persistent oral candidosis by non-albicans Candida strains including Candida glabrata in a human immunodeficiency virus-infected patient observed over a period of 6 years. Mycoses. 1998;41:335–8.
Hooper SJ, Wilson MJ, Crean SJ. Exploring the link between microorganisms and oral cancer: a systematic review of the literature. Head Neck. 2009;31:1228–39.
Hube B, Naglik J. Extracellular hydrolyses. In: Calderone RA, editor. Candida and candidiasis. Washington, DC: American Society for Microbiology (ASM) Press; 2002. p. 107–22.
Hube B, Stehr F, Bossenz M, Mazur A, Kretschmar M, Schäfer W. Secreted lipases of Candida albicans: cloning, characterisation and expression analysis of a new gene family with at least ten members. Arch Microbiol. 2000;174:362–74.
Iatta R, Napoli C, Borghi E, Montagna MT. Rare mycoses of the oral cavity: a literature epidemiologic review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108(5):647–55.
Iqbal F, Schifter M, Coleman HG. Oral presentation of histoplasmosis in an immunocompetent patient: a diagnostic challenge. Aust Dent J. 2014;59(3):386–8.
Jacobsen ID, Wilson D, Wachtler B, Brunke S, Naglik JR, Hube B. Candida albicans dimorphism as a therapeutic target. Expert Rev Anti Infect Ther. 2012;10(1):85–93.
Klatt JC, Grobe A, Schmelzle R, Atac A, Heiland M, Blessmann M, Pohlenz P. A series of complications after third molar osteotomy in a pancytopenia patient and spontaneous healing after bone marrow transplantation. J Oral Maxillofac Surg. 2011;69(10):2508–12.
Klein G, Klein E. Evolution of tumours and the impact of molecular oncology. Nature. 1985;315(6016):190–5.
Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev. 2004;17:255–67.
Krogh P. The role of yeasts in oral cancer by means of endogenous nitrosation. Acta Odontol Scand. 1990;48(1):85–8.
Krogh P, Hald B, Holmstrup P. Possible mycological etiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzylmethylamine. Carcinogenesis. 1987a;8(10):1543–8.
Krogh P, Holmstrup P, Thorn JJ, Vedtofte P, Pindborg JJ. Yeast species and biotypes associated with oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol. 1987b;63(1):48–54.
Kurkivuori J, Salaspuro V, Kaihovaara P, Kari K, Rautemaa R, Grönroos L, Meurman JH, Salaspuro M. Acetyldehyde production from ethanol from by oral streptococci. Oral Oncol. 2007;43:181–6.
La Vecchia C, Tavani A, Franceschi S, Levi F, Corrao G, Negri E. Epidemiology and prevention of oral cancer. Oral Oncol. 1997;33(5):302–12.
LaFleur MD, Kumamoto CA, Lewis K. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother. 2006;50(11):3839–46.
Lalla RV, Patton LL, Dongari-Bagtzoglou A. Oral candidiasis: pathogenesis, clinical presentation, diagnosis and treatment strategies. J Calif Dent Assoc. 2013;41(4):263–8.
Lamey PJ, Lewis MA, MacDonald DG. Treatment of candidal leukoplakia with fluconazole. Br Dent J. 1989;166(8):296–8.
Lax AJ, Thomas W. How bacteria could cause cancer: one step at a time. Trends Microbiol. 2002;10:293–9.
Li L, Redding S, Dongari-Bagtzoglou A. Candida glabrata: an emerging oral opportunistic pathogen. J Dent Res. 2007;86(3):204–15.
Lijinsky W, Saavedra JE, Reuber MD, Singer SS. Esophageal carcinogenesis in F344 rats by nitrosomethylethylamines substituted in the ethyl group. J Natl Cancer Inst. 1982;68:681–4.
Lilic D, Cant AJ, Abinun M, Calvert JE, Spickett GP. Chronic mucocutaneous candidiasis. I. Altered antigen-stimulated IL-2, IL-4, IL-6 and interferon-gamma (IFN-gamma) production. Clin Exp Immunol. 1996;105(2):205–12.
Liu Y, Filler SG. Candida albicans Als3, a multifunctional adhesin and invasin. Eukaryot Cell. 2011;10(2): 168–73.
Liu X, Hua H. Oral manifestation of chronic mucocutaneous candidiasis: seven case reports. J Oral Pathol Med. 2007;36(9):528–32.
Mah TF, O’Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 2001;9(1): 34–9.
Manfredi M, McCullough MJ, Al-Karaawi ZM, Hurel SJ, Porter SR. The isolation, identification and molecular analysis of Candida spp. isolated from the oral cavities of patients with diabetes mellitus. Oral Microbiol Immunol. 2002;17:181–5.
Manfredi M, McCullough MJ, Al-Karaawi ZM, Vescovi P, Porter SR. In vitro evaluation of virulence attributes of Candida spp. isolated from patients affected by diabetes mellitus. Oral Microbiol Immunol. 2006;21(3): 183–9.
Manfredi M, Polonelli L, Aguirre-Urizar JM, Carrozzo M, McCullough MJ. Urban legends series: oral candidosis. Oral Dis. 2013;19(3):245–61.
Mankowski ZT. Influence of Candida albicans glycoprotein on 3-methylcholanthrene induced malignancy in newborn rodents. Mycopathol Mycol Appl. 1971;44(2):95–100.
Mateus C, Crow SA Jr, Ahearn DG. Adherence of Candida albicans to silicone induces immediate enhanced tolerance to fluconazole. Antimicrob Agents Chemother. 2004;48(9):3358–66.
McCullough MJ, Savage NW. Oral candidosis and the therapeutic use of antifungal agents in dentistry. Aust Dent J. 2005;50(4 Suppl 2):S36–9.
McCullough M, Ross BC, Reade PC. Candida albicans: a review of its history, taxonomy, epidemiology, virulence attributes and methods of strain differentaiation. Int J Oral Maxillofac Surg. 1996;25:136–44.
McCullough MJ, Clemons KV, Stevens DA. Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. J Clin Microbiol. 1999a;37(2):417–21.
McCullough MJ, Clemons KV, Stevens DA. Molecular epidemiology of the global and temporal diversity of Candida albicans. Clin Infect Dis. 1999b;29(5): 1220–5.
McCullough MJ, DiSalvo AF, Clemons KV, Park P, Stevens DA. Molecular epidemiology of Blastomyces dermatitidis. Clin Infect Dis. 2000;30(2):328–35.
McCullough M, Jaber M, Barrett AW, Bain L, Speight PM, Porter SR. Oral yeast carriage correlates with presence of oral epithelial dysplasia. Oral Oncol. 2002;38(4):391–3.
Mehrabi M, Bagheri S, Leonard MK Jr, Perciaccante VJ. Mucocutaneous manifestation of cryptococcal infection: report of a case and review of the literature. J Oral Maxillofac Surg. 2005;63(10):1543–9.
Metzen D, Bohm H, Zimmermann M, Reuther T, Kubler AC, Muller-Richter UD. Mucormycosis of the head and neck. J Craniomaxillofac Surg. 2012;40(8):e321–7.
Meyer SA, Aheran DG, Yarrow DG. The genus Candida. In: The yeasts: a taxonomic study. Amsterdam: Elsevier; 1984. p. 585–844.
Midtvedt T. Ecosystems: development, functions and consequences of disturbances, with special reference to the oral cavity. J Clin Periodontol. 1990;17:474–8.
Moran GP, Sullivan DJ, Coleman DC. Emergence of non-Candida albicans Candida species as pathogens, chap. 4. In: Calderone RA, editor. Candida and Candidiasis. 4th ed. Washington, DC: ASM Press; 2002. p. 37–53.
Muadcheingka T, Tantivitayakul P. Distribution of Candida albicans and non-albicans Candida species in oral candidiasis patients: correlation between cell surface hydrophobicity and biofilm forming activities. Arch Oral Biol. 2015;60(6):894–901.
Naglik J, Albrecht A, Bader O, Hube B. Candida albicans proteinases and host/pathogen interactions. Cell Microbiol. 2004;6(10):915–26.
Nagy KN, Sonkodi I, Szöke I, Nagy E, Newman HN. The microflora associated with human oral carcinomas. Oral Oncol. 1998;34:304–8.
Negri M, Martins M, Henriques M, Svidzinski TI, Azeredo J, Oliveira R. Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients. Mycopathologia. 2010;169(3):175–82.
Neppelenbroek K, Seo R, Urban V, Silva S, Dovigo L, Jorge J, Campanha N. Identification of Candida species in the clinical laboratory: a review of conventional, commercial, and molecular techniques. Oral Dis. 2013;20:329.
Netea MG, Gow NA, Munro CA, Bates S, Collins C, Ferwerda G, Hobson RP, Bertram G, Hughes HB, Jansen T, Jacobs L, Buurman ET, Gijzen K, Williams DL, Torensma R, McKinnon A, MacCallum DM, Odds FC, Van der Meer JW, Brown AJ, Kullberg BJ. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and toll-like receptors. J Clin Invest. 2006;116(6):1642–50.
Nucci M, Marr KA. Emerging fungal diseases. Clin Infect Dis. 2005;41(4):521–6.
O’Grady JF, Reade PC. Candida albicans as a promoter of oral mucosal neoplasia. Carcinogenesis. 1992;13: 783–6.
O’Toole GA, Kaplan HB, Kolter R. Biofilm formation as microbial development. Annu Rev Microbiol. 2000;54:49–79.
Odds FC. Candida and candidosis-a review and bibliography. 2nd ed. London: Bailliere Tindall; 1988.
Odds FC. Candida albicans, the life and times of a pathogenic yeast. J Med Vet Mycol. 1994a;32(Suppl 1):1–8.
Odds FC. Pathogenesis of Candida infections. J Am Acad Dermatol. 1994b;31(3 Pt 2):S2–5.
Odds FC, Abbott AB. A simple system for the presumptive identification of Candida albicans and differentiation of strains within the species. Sabouraudia. 1980;18: 301–17.
Oksala E. Factors predisposing to oral yeast infections. Acta Odontol Scand. 1990;48:71–4.
Paraje MG, Correa SG, Albesa I, Sotomayor CE. Lipase of Candida albicans induces activation of NADPH oxidase and l-arginine pathways on resting and activated macrophages. Biochem Biophys Res Commun. 2009;390(2):263–8.
Patil PM, Bhadani P. Extensive maxillary necrosis following tooth extraction. J Oral Maxillofac Surg. 2011;69(9):2387–91.
Patil S, Rao RS, Majumdar B, Anil S. Clinical appearance of oral candida infection and therapeutic strategies. Front Microbiol. 2015;6:1391.
Pedreira Rdo P, Guimaraes EP, de Carli ML, Magalhaes EM, Pereira AA, Hanemann JA. Paracoccidioidomycosis mimicking squamous cell carcinoma on the dorsum of the tongue and review of published literature. Mycopathologia. 2014;177(5–6): 325–9.
Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002;2(1):28–37.
Peman J, Zaragoza R, Quindos G, Alkorta M, Cuetara MS, Camarena JJ, Ramirez P, Gimenez MJ, Martin-Mazuelos E, Linares-Sicilia MJ, Ponton J. Clinical factors associated with a Candida albicans germ tube antibody positive test in intensive care unit patients. BMC Infect Dis. 2011;11:60.
Pfaller MA. Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin Infect Dis. 1996;22(Suppl 2):S89–94.
Philip M, Rowley DA, Schreiber H. Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol. 2004;14:433–9.
Pindborg JJ. Oral cancer and precancer. Bristol: John Wright and sons; 1980.
Pinjon E, Moran GP, Coleman DC, Sullivan DJ. Azole susceptibility and resistance in Candida dubliniensis. Biochem Soc Trans. 2005;33:1210–4.
Porter SR, Scully C. Chronic mucocutaneous candidosis and related syndromes, Chap. 11. In: Samaranayake LP, MacFarlane TW, editors. Oral candidosis. London: Wright-Butterworth and Co Ltd; 1990.
Qi QG, Hu T, Zhou XD. Frequency, species and molecular characterization of oral Candida in hosts of different age in China. J Oral Pathol Med. 2005;34:352–6.
Radford DR, Sweet SP, Challacombe SJ, Walter JD. Adherence of Candida albicans to denture-base materials with different surface finishes. J Dent. 1998;26:577–83.
Rajendran R, Robertson DP, Hodge PJ, Lappin DF, Ramage G. Hydrolytic enzyme production is associated with Candida albicans biofilm formation from patients with type 1 diabetes. Mycopathologia. 2010;170:229–35.
Rautemaa R, Ramage G. Oral candidosis–clinical challenges of a biofilm disease. Crit Rev Microbiol. 2011;37:328–36.
Rautemaa R, Rusanen P, Richardson M, Meurman JH. Optimal sampling site for mucosal candidosis in oral cancer patients is the labial sulcus. J Med Microbiol. 2006;55:1447–51.
Redding SW. The role of yeasts other than Candida albicans in oropharyngeal candidiasis. Curr Opin Infect Dis. 2001;14:673–7.
Redding SW, Kirkpatrick WR, Coco BJ, Sadkowski L, Fothergill AW, Rinaldi MG, Eng TY, Patterson TF. Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer. J Clin Microbiol. 2002;40:1879–81.
Reed MF, Scragg MA, Williams DM, Soames JV. In vivo effects of Candida albicans products on rat oral epithelium. J Oral Pathol Med. 1990;19(7):326–9.
Reichart PA, Samaranayake LP, Philipsen HP. Pathology and clinical correlates in oral candidiasis and its variants: a review. Oral Dis. 2000;6:85–91.
Renstrup G. Occurrence of Candida in oral leukoplakias. Acta Pathol Microbiol Scand B: Microbiol Immunol. 1970;78:421–4.
Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, Edwards JEJ. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis. 2000;30:662–78.
Reznik DA. Oral manifestations of HIV disease. Top HIV Med. 2005;13(5):143–8.
Rindum JL, Stenderup A, Holmstrup P. Identification of Candida albicans types related to healthy and pathological oral mucosa. J Oral Pathol Med. 1994;23(9): 406–12.
Romani L. Immunity to fungal infections. Nat Rev Immunol. 2004;4(1):1–23.
Romani L, Bistoni F, Puccetti P. Fungi, dendritic cells and receptors: a host perspective of fungal virulence. Trends Microbiol. 2002;10(11):508–14.
Ruhnke M, Schmidt-Westhausen A, Morschhäuser J. Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS. J Antimicrob Chemother. 2000;46:291–5.
Ruoslahti E. How cancer spreads. Sci Am. 1996;267:42–7.
Salaspuro MP. Acetyldehyde, microbes and cancer of the digestive tract. Crit Rev Clin Lab Sci. 2003;40: 183–208.
Samaranayake LP. Host factors and oral candidosis. In: Samaranayake LP, MacFarlane TW, editors. Oral candidosis. London: Wright-Butterworth & Co. Ltd; 1990. p. 66–104.
Samaranayake LP. Oral mycoses in HIV infection. Oral Surg Oral Med Oral Pathol. 1992;73:171–80.
Samaranayake LP, Yaacob HB. Classification of oral candidosis. In: Samaranayake LP, MacFarlane TW, editors. Oral candidosis. London: Wright-Butterworth and Co. Ltd; 1990. p. 124–32.
Samaranayake LP, Fidel PL, Naglik JR, Sweet SP, Teanpaisan R, Coogan MM, Blignaut E, Wanzala P. Fungal infections associated with HIV infection. Oral Disease. 2002;8:151–60.
Samaranayake LP, Keung Leung W, Jin L. Oral mucosal fungal infections. Periodontol 2000. 2009;49:39–59.
Sanglard D, Bille J. Current understanding of the modes of action and resistance mechanisms to conventional and emerging antifungal agents for treatment of Candida infections. In: Calderone RA, editor. Candida and candidiasis. Washington, DC: American Society for Microbiology (ASM) Press; 2002. p. 349–83.
Sargenti Neto S, Paulo LF, Rosa RR. Oral paracoccidioidomycosis as a differential diagnosis of oral cancer. Rev Soc Bras Med Trop. 2012;45(6):777.
Schaller M, Januschke E, Schackert C, Woerle B, Korting HC. Different isoforms of secreted aspartyl proteinases (Sap) are expressed by Candida albicans during oral and cutaneous candidosis in vivo. J Med Microbiol. 2001;50(8):743–7.
Schaller M, Mailhammer R, Korting HC. Cytokine expression induced by Candida albicans in a model of cutaneous candidosis based on reconstituted human epidermis. J Med Microbiol. 2002;51:672–6.
Schaller M, Borelli C, Korting HC, Hube B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses. 2005;48:365–77.
Schauer F, Hanschke R. [Taxonomy and ecology of the genus Candida]. Mycoses. 1999;42 Suppl 1:12–21.
Scolozzi P, Perez A, Verdeja R, Courvoisier DS, Lombardi T. Association between maxillary sinus fungus ball and sinus bone grafting with deproteinized bovine bone substitutes: a case-control study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121(6):e143–7.
Scully C. Candida and candidosis. World workshop on oral medicine. 1988. p. 191–7. Chicago, June,1988.
Scully C, el-Kabir M, Samaranayake LP. Candida and oral candidosis: a review. Crit Rev Oral Biol Med. 1994;5(2):125–57.
Scully C, Flint SR, Porter SR, Moos KF. Oral and maxillofacial diseases. London: Taylor & Francis; 2004.
Selmecki A, Forche A, Berman J. Genomic plasticity of the human fungal pathogen Candida albicans. Eukaryot Cell. 2010;9(7):991–1008.
Shakir BS, Smith CJ, Martin MV. Epithelial mitotic activity during the induction of palatal candidosis in the Wistar rat. J Oral Pathol. 1986;15(7):375–80.
Shapiro RS, Cowen L. Coupling temperature sensing and development: Hsp90 regulates morphogenetic signalling in Candida albicans. Virulence. 2010;1(1):45–8.
Sharon V, Fazel N. Oral candidiasis and angular cheilitis. Dermatol Ther. 2010;23(3):230–42.
Sherman RG, Prusinski L, Ravenel MC, Joralmon RA. Oral candidosis. Quintessence Int. 2002;33: 521–32.
Silva S, Henriques M, Oliveira R, Williams D, Azeredo J. In vitro biofilm activity of non-Candida albicans Candida species. Curr Microbiol. 2010;61(6):534–40.
Simon GB, Berson SD, Young CN. Blastomycosis of the tongue: a case report. S Afr Med J. 1977;52(2):82–3.
Singh V, Sharma B, Sen R, Agrawal S, Bhagol A, Bali R. Rhinocerebral mucormycosis: a diagnostic challenge and therapeutic dilemma in immunocompetent host. J Oral Maxillofac Surg. 2012;70(6):1369–75.
Singh V, Gupta P, Khatana S, Bhagol A, Gupta A. A nonhealing ulcer of mandibular alveolar ridge. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(3):272–6.
Sitheeque MA, Samaranayake LP. Chronic hyperplastic candidosis/candidiasis (candidal leukoplakia). Crit Rev Oral Biol Med. 2003;14(4):253–67.
Smith EM, Hoffman HT, Summersgill KS, Kirchner HL, Turek LP, Haugen TH. Human papillomavirus and risk of oral cancer. Laryngoscope. 1998;108(7):1098–103.
Sohn DS, Lee JK, Shin HI, Choi BJ, An KM. Fungal infection as a complication of sinus bone grafting and implants: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107(3):375–80.
Soysa NS, Samaranayake LP, Ellepola AN. Antimicrobials as a contributory factor in oral candidosis–a brief overview. Oral Dis. 2008;14:138–43.
Spampinato C, Leonardi D. Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents. Biomed Res Int. 2013;2013:204237.
Srivastava N, Bansal V, Kantoor P. Palatal mucormycosis in an infant. J Dent Child (Chic). 2015;82(3):153–6.
Stehr F, Felk A, Gacser A, Kretschmar M, Mahnss B, Neuber K, Hube B, Schafer W. Expression analysis of the Candida albicans lipase gene family during experimental infections and in patient samples. FEMS Yeast Res. 2004;4(4–5):401–8.
Stevens DA, Odds FC, Scherer S. Application of DNA typing methods to Candida albicans epidemiology and correlations with phenotype. Rev Infect Dis. 1990;12(2):258–66.
Stokes C, Moran GP, Spiering MJ, Cole GT, Coleman DC, Sullivan DJ. Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans. Fungal Genet Biol. 2007;44:920–31.
Strausbaugh LJ, Sewell DL, Ward TT, Pfaller MA, Heitzman T, Tjoelker R. High frequency of yeast carriage on hands of hospital personnel. J Clin Microbiol. 1994;32(9):2299–300.
Sullivan D, Coleman D. Candida dubliniensis: characteristics and identification. J Clin Microbiol. 1998;36(2): 329–34.
Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology. 1995;141:1507–21.
Taff HT, Nett JE, Andes DR. Comparative analysis of Candida biofilm quantitation assays. Med Mycol. 2011;50:214.
Taschdjian CL, Seelig MS, Kozinn PJ. Serological diagnosis of candidal infections. CRC Crit Rev Clin Lab Sci. 1973;4(1):19–59.
ten Cate JM, Klis FM, Pereira-Cenci T, Crielaard W, de Groot PW. Molecular and cellular mechanisms that lead to Candida biofilm formation. J Dent Res. 2009;88:105–15.
Thomas J, Munson E, Christianson JC. Unexpected Blastomyces dermatitidis etiology of fungal sinusitis and erosive palatal infection in a diabetic patient. J Clin Microbiol. 2014;52(8):3130–3.
Tillonen J, Homann N, Rautio M, Jousimies-Somer H, Salaspuro M. Role of yeasts in the salivary acetaldehyde production from ethanol among risk groups for ethanol-associated oral cavity cancer. Alcohol Clin Exp Res. 1999;23:1409–15.
Tsang CS, Chu FC, Leung WK, Jin LJ, Samaranayake LP, Siu SC. Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus. J Med Microbiol. 2007;56(Pt 10):1393–8.
Tumbarello M, Caldarola G, Tacconelli E, Morace G, Posteraro B, Cauda R, Ortona L. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection. J Antimicrob Chemother. 1996;38:691–9.
Tunnet MM, Gorman SP, Patrick S. Infection associated with medical devices. Rev Med Microbiol. 1996;7:195–205.
Tzerbos F, Kabani S, Booth D. Cryptococcosis as an exclusive oral presentation. J Oral Maxillofac Surg. 1992;50(7):759–60.
Ueta E, Osaki T, Yoneda K, Yamamoto T. Prevalence of diabetes mellitus in odontogenic infections and oral candidiasis: an analysis of neutrophil suppression. J Oral Pathol Med. 1993;22(4):168–74.
Uittamo J, Siikala E, Kaihovaara P, Salaspuro M, Rautemaa R. Chronic candidosis and oral cancer in APECED-patients: production of carcinogenic acetaldehyde from glucose and ethanol by Candida albicans. Int J Cancer. 2009;124(3):754–6.
Uittamo J, Nieminen MT, Kaihovaara P, Bowyer P, Salaspuro M, Rautemaa R. Xylitol inhibits carcinogenic acetaldehyde production by Candida species. Int J Cancer. 2011;129(8):2038–41.
Umadevi M, Adeyemi O, Patel M, Reichart PA, Robinson PG. (B2) periodontal diseases and other bacterial infections. Adv Dent Res. 2006;19(1):139–45.
Urs AB, Singh H, Nunia K, Mohanty S, Gupta S. Post endodontic Aspergillosis in an immunocompetent individual. J Clin Exp Dent. 2015;7(4):e535–9.
Urs AB, Singh H, Mohanty S, Sharma P. Fungal osteomyelitis of maxillofacial bones: rare presentation. J Oral Maxillofac Pathol. 2016;20(3):546.
Väkeväinen S, Mentula S, Nuutinen H, Salmela KS, Jousimies-Somer H, Färkkilä M, Salaspuro M. Ethanol derived microbial production of carcinogenic acetyldehyde in achlorhydric atrophic gastritis. Scand J Gastroenterol. 2002;37:648–55.
van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LA, Gilissen C, Arts P, Rosentul DC, Carmichael AJ, Smits-van der Graaf CA, Kullberg BJ, van der Meer JW, Lilic D, Veltman JA, Netea MG. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med. 2011;365(1):54–61.
Vazquez JA. Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection. HIV AIDS (Auckl). 2010;2:89–101.
Vazquez JA, Sanchez V, Dmuchowski C, Dembry LM, Sobel JD, Zervos MJ. Nosocomial acquisition of Candida albicans: an epidemiologic study. J Infect Dis. 1993;168:195–201.
Vidya KM, Rao UK, Nittayananta W, Liu H, Owotade FJ. Oral mycoses and other opportunistic infections in HIV: therapy and emerging problems – a workshop report. Oral Dis. 2016;22(Suppl 1):158–65.
Vinay BH, Mohan A, Haritha P, Lakshmi KR. A rare coexistence of aspergillosis with actinomycosis. J Oral Maxillofac Pathol. 2017;21(2):277–81.
Viudes A, Pemán J, Cantón E, Salavert M, Ubeda P, López-Ribot JL, Gobernado M. Two cases of fungemia due to Candida lusitaniae and a literature review. Eur J Clin Microbiol Infect Dis. 2002;21:294–9.
Wachtler B, Wilson D, Haedicke K, Dalle F, Hube B. From attachment to damage: defined genes of Candida albicans mediate adhesion, invasion and damage during interaction with oral epithelial cells. PLoS One. 2011;6(2):e17046.
Weinberg RA. How cancer arises. Sci Am. 1996;275:62–70.
Williams D, Lewis M. Pathogenesis and treatment of oral candidosis. J Oral Microbiol. 2011;3:5771–82.
Williams DW, Bartie KL, Potts AJ, Wilson MJ, Fardy MJ, Lewis MA. Strain persistence of invasive Candida albicans in chronic hyperplastic candidosis that underwent malignant change. Gerodontology. 2001;18:73–80.
Williams DW, Kuriyama T, Silva S, Malic S, Lewis MA. Candida biofilms and oral candidosis: treatment and prevention. Periodontol 2000. 2011;55(1):250–65.
Williamson D. Chronic hyperplastic candidiasis and squamous cell carcinoma. Br J Dermatol. 1969;81:125–7.
Willis AM, Coulter WA, Fulton CR, Hayes JR, Bell PM, Lamey PJ. Oral candidal carriage and infection in insulin-treated diabetic patients. Diabet Med. 1999;16:675–9.
Yoon SA, Vazquez JA, Steffan PE, Sobel JD, Akins RA. High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance. Antimicrob Agents Chemother. 1999;43:836–45.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this entry
Cite this entry
Manfredi, M., Polonelli, L., Giovati, L., Alnuaimi, A., McCullough, M.J. (2018). Oral and Maxillofacial Fungal Infections. In: Farah, C., Balasubramaniam, R., McCullough, M. (eds) Contemporary Oral Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-28100-1_1-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-28100-1_1-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28100-1
Online ISBN: 978-3-319-28100-1
eBook Packages: Springer Reference MedicineReference Module Medicine